Breast-conserving therapy for early-stage cancers has increased substantially, though access remains an issue

The first comprehensive national review of breast-conserving therapy (BCT) shows that over the last 13 years rates of this treatment modality for early-stage breast cancer have increased at a steady pace. However, the review also highlights important demographic factors that impact which patients have access to BCT. (Mehr in: Cancer News — ScienceDaily)